Published online Feb 28, 2014. doi: 10.3748/wjg.v20.i8.2071
Revised: November 15, 2013
Accepted: December 3, 2013
Published online: February 28, 2014
Processing time: 205 Days and 19.6 Hours
AIM: To investigate the mechanisms of chloride intracellular channel 1 (CLIC1) in the metastasis of colon cancer under hypoxia-reoxygenation (H-R) conditions.
METHODS: Fluorescent probes were used to detect reactive oxygen species (ROS) in LOVO cells. Wound healing assay and transwell assay were performed to examine the migration and invasion of LOVO cells. Expression of CLIC1 mRNA and protein, p-ERK, MMP-2 and MMP-9 proteins was analyzed by reverse transcription-polymerase chain reaction and Western blot.
METHODS: H-R treatment increased the intracellular ROS level in LOVO cells. The mRNA and protein expression of CLIC1 was elevated under H-R conditions. Functional inhibition of CLIC1 markedly decreased the H-R-enhanced ROS generation, cell migration, invasion and phosphorylation of ERK in treated LOVO cells. Additionally, the expression of MMP-2 and MMP-9 could be regulated by CLIC1-mediated ROS/ERK pathway.
CONCLUSION: Our results suggest that CLIC1 protein is involved in the metastasis of colon cancer LOVO cells via regulating the ROS/ERK pathway in the H-R process.
Core tip: Hypoxia-reoxygenation (H-R) treatment increases the intracellular reactive oxygen species (ROS) level to activate the MAPK/ERK pathway, resulting in the promotion of migration and invasion in colon cancer LOVO cells. Inhibition of chloride intracellular channel 1 (CLIC1) using specific inhibitor IAA94 can markedly decrease the H-R-enhanced ROS generation, migration, invasion and phosphorylation of ERK. The results presented in the current study suggest that CLIC1 is involved in the metastasis of colon cancer LOVO cells via regulating the ROS/ERK pathway in the H-R process.